Terms, Abbreviations, and Acronyms
The information on this page reflects the 2024 acute and chronic HBV case definition updates. FOR 2023 HBV CASE CLASSIFICATION, use: 2023 Case Classification_Full Guidance PDF
Gender-neutral terminology will be used throughout for pregnant people, people of childbearing age with childbearing potential, and gestational parents. These terms are used to describe people who are pregnant, have the potential to become pregnant, or have physically given birth, to be inclusive of all gender identities.
| Use | Meaning |
|---|---|
| AASLD | American Association for the Study of Liver Diseases |
| ACIP | Advisory Committee on Immunization Practices |
| ACOG | American College of Obstetrics and Gynecologists |
| ALT | alanine aminotransferase |
| Anti-HAV IgG | immunoglobulin class G antibody to hepatitis A virus |
| Anti-HAV IgM | immunoglobulin class M antibody to hepatitis A virus |
| Anti-HBc IgM | immunoglobulin class M antibody to hepatitis B core antigen |
| Anti-HBe | hepatitis B e antibody |
| Anti-HBs | hepatitis B surface antibody |
| Anti-HCV | hepatitis C virus antibody |
| CDC | US Centers for Disease Control and Prevention |
| CFR | Code of Federal Regulations |
| CLIA | Clinical Laboratory Improvement Amendments |
| CMS | Centers for Medicare and Medicaid Services |
| CSTE | Council of State and Territorial Epidemiologists |
| DAA | direct-acting antiviral agents |
| DIS | disease investigation specialists |
| DNA | deoxyribonucleic acid |
| DVH | Division of Viral Hepatitis |
| DTAC | Disease Transmission Advisory Committee |
| EHR | electronic health record |
| ELR | electronic laboratory reporting |
| EMR | electronic medical record |
| FDA | US Food and Drug Administration |
| ICD-10 | International Statistical Classification of Diseases and Related Health Problems, Tenth Revision |
| IDU | injection drug use |
| IDSA | Infectious Diseases Society of America |
| HAI | health care-associated infections |
| HAV | hepatitis A virus |
| HBeAg | hepatitis B e antigen |
| HBIG | hepatitis B immunoglobulin |
| HBV | hepatitis B virus |
| HBsAg | hepatitis B surface antigen |
| HCV | hepatitis C virus |
| HD | health department |
| HL7 | Health Level Seven |
| LGBTQ+ | lesbian, gay, bisexual, transgender, and queer plus |
| MAT | medication-assisted treatment for opioid use disorder |
| MMWR | Morbidity and Mortality Weekly Report |
| MOUD | medication for opioid use disorder |
| MSM | men who have sex with men |
| NASTAD | National Alliance of State and Territorial AIDS Directors |
| NAT | nucleic acid test |
| NBS | NEDSS-Base System |
| NCHHSTP | National Center for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Prevention |
| NEDSS | National Electronic Disease Surveillance System |
| NETSS | National Electronic Telecommunications System for Surveillance |
| NHANES | National Health and Nutrition Examination Survey |
| NNC | Nationally Notifiable Condition |
| NNDSS | National Notifiable Diseases Surveillance System |
| OB/GYN | Obstetrics and gynecology |
| OMB | Office of Management and Budget |
| OPHDST | Office of Public Health Data, Surveillance, and Technology |
| OPTN | Organ Procurement and Transplantation Network |
| PCR | polymerase chain reaction |
| PHBPP | Perinatal Hepatitis B Prevention Program |
| PHS | Public Health Services |
| PII | personally identifiable information |
| PreP | pre-exposure prophylaxis |
| PWID | people who inject drugs |
| PWUD | people who use drugs |
| PVST | post-vaccination serologic testing |
| RNA | ribonucleic acid |
| S/c | signal-to-cutoff |
| SSP | syringe services programs |
| STI | sexually transmitted infection |
| SUD | substance use disorder |
| TA | technical assistance |
| Total anti-HAV | total antibody to hepatitis A virus |
| Total anti-HBc | total antibody to hepatitis B core antigen |